{"version":"1.0","type":"link","title":"Vemurafenib, cetuximab and camrelizumab in BRAF V600E-mutated/MSS metastatic colorectal cancer.","author_name":"Wei GX 외","author_url":"https://prs-insight.online/author/Wei%20GX","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/114465","thumbnail_width":1200,"thumbnail_height":630}